Target intelligence / Profile preview

Reactive oxygen species and radical-generating enzymes (ROS/RGE)

Target
ROS/RGE
Molecular classification
Enzyme, Reactive chemical species, Oxidoreductase
01

Overview

Reactive oxygen species (ROS) and radical-generating enzymes represent a diverse group of molecules and proteins that regulate the cellular redox environment. ROS, such as superoxide, hydrogen peroxide, and hydroxyl radicals, are generated as metabolic byproducts or through the activity of specialized enzymes like NADPH oxidases (NOX), xanthine oxidase, and myeloperoxidase (Sies & Jones, 2020). Under normal physiological conditions, these species act as secondary messengers in signaling pathways that control cell growth, immune activation, and vascular tone (Lambeth, 2004). However, the excessive accumulation of ROS, often termed oxidative stress, leads to the non-specific oxidation of DNA, proteins, and lipids, contributing to the pathogenesis of chronic diseases such as atherosclerosis, Alzheimer's disease, and various cancers (Phaniendra et al., 2015). Pharmacological strategies targeting this system include the use of small-molecule inhibitors to block specific ROS-producing enzymes or the administration of antioxidant compounds to scavenge reactive intermediates. While promising, these therapies must be carefully calibrated to avoid disrupting the essential roles ROS play in pathogen defense and homeostatic signaling (Di Meo et al., 2016).

Other names
ROSPro-oxidant enzymesOxidative stress mediatorsReactive oxygen species-generating enzymesRadical-generating enzymes
02

Mechanism of action

Inhibition of enzymatic ROS production, direct scavenging of reactive oxygen species, and induction of endogenous antioxidant defense systems.

03

Biological functions

Redox signalingInnate immune responseApoptosisCell proliferationVascular tone regulationHomeostasis
04

Disease associations

InflammationCardiovascular diseaseNeurodegenerative diseaseCancerDiabetes mellitusChronic kidney diseaseAging
05

Safety considerations

Impairment of innate immune responseDisruption of physiological redox signalingRisk of antioxidant paradoxPotential for off-target effects on beneficial ROS functions
06

Interacting drugs

Allopurinol

7 more in the full profile.

07

Biomarkers

8-isoprostaneMalondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Protein carbonylsGlutathione (GSH/GSSG) ratio

Beyond the preview

Go deeper on Reactive oxygen species and radical-generating enzymes (ROS/RGE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species and radical-generating enzymes (ROS/RGE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call